MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study

    D. Dos Santos, D. Freire Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To evaluate the feasibility and identify obstacles in conducting teleconsultations for patients with parkinsonism in the Brazilian public health system Background: Patients with parkinsonism…
  • MDS Virtual Congress 2021

    Efficacy of opicapone according to levodopa’s duration of use in Parkinson’s disease patients with motor fluctuations

    A. Antonini, G. Ebersbach, O. Rascol, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Padova, Italy)

    Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation (MF) according to levodopa’s duration of use. Background: OPC…
  • MDS Virtual Congress 2021

    Non-motor symptoms in Parkinson’s disease

    M. Elfekih, I. Bedoui, B. Douma, M. Mansour, H. Derbali, A. Riahi, M. Meselmani, J. Zaouali, R. Mrissa (Nabeul, Tunisia)

    Objective: The objective of our study is to assess the prevalence of non motor signs in patients with parkinson’s disease and to propose an adapted…
  • MDS Virtual Congress 2021

    Dual-task interference on weight-shifting in Parkinson’s Disease with freezing of gait and without freezing of gait

    YT. Hung, CY. Tsai, RM. Wu, CY. Huang (Taipei, Taiwan)

    Objective: To investigate the control of dual-task weight-shifting in Parkinson's disease (PD) with freezing of gait (FOG) and without FOG). Background: With more impairment in…
  • MDS Virtual Congress 2021

    Cuneiform Nucleus Deep Brain Stimulation for Freezing of Gait in Parkinson’s disease. Initial clinical report.

    C. Luca, S. Chang, I. Cajigas, J. Guest, I. Haq, B. Noga, J. Jagid (Miami, USA)

    Objective: Here we report a first in human targeting of Cuneiform Nucleus (CnF) using MR tractography, observation of intraoperative stimulation patterns and stimulation precision benefits of…
  • MDS Virtual Congress 2021

    A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson’s Disease Dementia.

    SH. Pasternak, C. Silviera, K. Coleman, E. Finger, J. Wells, M. Borrie, S. Morrow, G. Zou, R. Bartha, P. Macdonald, ME. Jenkins, M. Jog, R. Tirona, CA. Rupar (London, Canada)

    Objective: Currently there are no disease-treatments for Synucleinopathies including Parkinson’s disease dementia (PDD). Our objective is to use Ambroxol to target GBA/Glucocerebrosidase to treat PDD.…
  • MDS Virtual Congress 2021

    Secondary endpoints of a randomized, placebo-Controlled Pilot Study to evaluate the safety of lyophilized PRIM-DJ2727 in Parkinson’s disease

    J. Suescun, M. Schiess, Z. Jiang, V. Thyne, T. Iqbal, N. Utay, M. Newmark, A. Dupont, A. Alexander, H. Dupont (Houston, USA)

    Objective: To evaluate the impact of fecal microbiome transplant (FMT) on disease progression as a secondary outcome of a safety study using PRIM-DJ2727 in Parkinson's…
  • MDS Virtual Congress 2021

    The effect of medical xenon on patients with advanced stages of the Parkinson’s disease with motor fluctuations

    R. Bogdanov, E. Vasilchenko, A. Dobrovolsky, P. Ratmanova, D. Napalkov, V. Bogin (Moscow, Russian Federation)

    Objective: The aim of the study to increase the effectiveness of pharmacotherapy in patients with advanced stages of Parkinson's disease (PD) with motor fluctuations, using…
  • MDS Virtual Congress 2021

    Classification of Advanced Parkinson’s Disease in OBSERVE-PD Patients Based on the MANAGE-PD Screening Tool

    A. Fasano, V. Fung, K. Seppi, Z. Pirtosek, L. Bergmann, A. Alobaidi, K. Onuk (Toronto, Canada)

    Objective: This post-hoc analysis evaluated uncontrolled patients from OBSERVE-PD identified as advanced Parkinson’s disease (APD) based on domains evaluated in section 2 of the MANAGE-PD…
  • MDS Virtual Congress 2021

    IS THE HYPOXIA EXPOSURE BENEFICIAL FOR PEOPLE WITH PARKINSON’S DISEASE? A SCOPE REVIEW

    C. Kalva-Filho, M. Kuroda, E. Costa, J. Corradini, F. Barbieri (Bauru, Brazil)

    Objective: To explore the current evidence and identify knowledge gaps, we conducted a scoping review about the hypoxia exposure effects on people with Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley